[HTML][HTML] Precision medicine for risk prediction of oral complications of cancer therapy–The example of oral mucositis in patients receiving radiation therapy for cancers …

ST Sonis - Frontiers in Oral Health, 2022 - frontiersin.org
Oral complications of cancer therapy are common, markedly symptomatic, negatively impact
patients' quality of life, and add significantly to the cost of care. Patients' risk of treatment …

Comparison of two cisplatin regimens for chemoradiation in patients with squamous-cell carcinoma of the head and neck

I Zwaan, T Soror, KL Bruchhage, SG Hakim… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Many patients with squamous-cell carcinoma of the head and neck receive
cisplatin-based chemoradiation. This retrospective study compared two chemoradiation …

Risk factors for xerostomia following radiotherapy of head-and-neck cancers

B Warwas, F Cremers, K Gerull, A Leichtle… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Many head-and-neck cancer patients receive radiotherapy, which may be
associated with significant toxicities. Xerostomia is considered one of the most debilitating …

Prognostic factors for complete recovery from xerostomia after radiotherapy of head-and-neck cancers

D Rades, B Warwas, K Gerull, R Pries, A Leichtle… - in vivo, 2022 - iv.iiarjournals.org
Background/Aim: Radiotherapy of head-and-neck cancers can cause xerostomia. This study
investigated potential prognostic factors for complete recovery from this complication …

Impact of dose-volume parameters of parotid glands on xerostomia in patients irradiated for head-and-neck cancer

D Rades, B Warwas, F Cremers, K Gerull… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Optimal planning of radiotherapy for head-and-neck cancers should
consider the risk of xerostomia. This study investigated the prognostic value of dosevolume …

[HTML][HTML] Management and outcome of locally advanced oral squamous cell carcinoma

RN Bera, S Tandon, AK Singh… - National Journal of …, 2023 - journals.lww.com
Management of locally advanced OSCC is multimodal. No single therapy has been proved
to be efficacious. However there is a trend towards surgical intervention in operable disease …

A comparative and prospective study of two different radiation fractionation schedules with concurrent chemotherapy in locally advanced head-and-neck squamous …

C Roy, L Biswas, A Roy, S Sharma… - Asian Journal of …, 2022 - search.ebscohost.com
Background: Accelerated fractionation radiotherapy has radiobiological advantage of
preventing accelerated tumor repopulation and logistic advantage of treating more patients …